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Hepatitis C virus (HCV) RNA replication requires cellular factors as well as viral non-structural
proteins (NS protein). Using small interfering RNA (siRNA) library screening, we previously identi-
ﬁed c-Fos as a host factor involved in HCV propagation. In the present study, we demonstrated that
silencing of c-Fos expression resulted in decrease of HCV propagation in cell culture grown HCV
(HCVcc)-infected cells; whereas overexpression of c-Fos signiﬁcantly increased HCV propagation.
We further conﬁrmed the positive role of c-Fos in HCV propagation by both HCV-luciferase reporter
assay and immunoﬂuorescence analysis. We showed that c-Fos level was upregulated by HCV infec-
tion. Furthermore, phorbol 12-myristate 13-acetate (PMA)-induced c-Fos level was synergistically
increased by HCV infection. These data suggest that c-Fos acts as a positive regulator of HCV prop-
agation and may contribute to HCV-associated pathogenesis.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Hepatitis C virus (HCV) is a major cause of non-A, non-B hep-
atitis, which often leads to chronic hepatitis, liver cirrhosis and
ultimately hepatocellular carcinoma (HCC) [1]. Approximately,
170 million individuals worldwide are chronically infected with
HCV. However, the molecular mechanisms that lead to HCC by
HCV are poorly understood. HCV is an enveloped, positive-sense
RNA virus classiﬁed in the Hepacivirus genus within the Flaviviri-
dae family [2]. HCV is highly heterogeneous and has been classi-
ﬁed into six major genotypes and numerous subtypes [3]. The
9.6-kb HCV genome encodes a large open reading frame (ORF)
ﬂanked by highly structured untranslated regions (UTRs) at the
50 and 30 end. The translation of the ORF results in a precursor
polyprotein of more than 3010 amino acids that is cleaved by cel-
lular and viral proteases into 3 structural (core, E1, and E2) and 7
non-structural (p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B)chemical Societies. Published by E
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g).proteins. The non-structural proteins (NS protein) regulate viral
RNA replication. Among the HCV proteins, core, NS3, and NS5A
proteins are typical multifunctional proteins. These proteins inter-
act with many host proteins, and regulate signal transduction
pathways and cellular events including, interferon response,
apoptosis, and cell proliferation. Therefore, any cellular target that
can interrupt these pathways and events will be a putative target
for HCV therapy.
c-Fos, the cellular counterpart of the viral oncogene v-Fos, is a
proto-oncogene belonging to the immediate early gene family of
transcription factors. c-Fos expression in quiescent cells is nor-
mally very low, but is rapidly inducible by extracellular signals
[4]. c-Fos is a part of the activated protein-1 (AP-1) transcription
factor that is participated in cell proliferation, differentiation,
apoptosis, and transformation. Both extra and intracellular stimuli
induce transcriptional activity of Fos/Ap-1. The activated Fos/Ap-1
regulates various cellular functions and pathological conditions,
including cancer. However, the molecular mechanism of c-Fos in
HCV-induced liver pathogenesis is not delineated yet.
Our study showed that c-Fos was involved in HCV propagation.
HCV infection increased c-Fos expression level. RNA interference of
c-Fos expression led to a decrease in HCV propagation; whereas
overexpression of c-Fos resulted in increase in HCV propagation.
These studies indicate that c-Fos positively regulates HCV propa-
gation.lsevier B.V. All rights reserved.
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2.1. Plasmid construction
Full-length human c-Fos cDNA was ampliﬁed by using pME18S-
Fos plasmid (21C Frontier Human Gene Bank) and subcloned into
the pFlag-CMV10 (Sigma–Aldrich) vector to generate Flag-c-Fos
expression plasmid. Jc1, JFH1-Luc, and Jc1-GFP plasmids were
kindly provided by Dr. Ralf Bartenschlager (University of Heidel-
berg, Heidelberg).
2.2. Cell culture, transfection, and generation of infectious HCV
All cell lines were grown in Dulbecco’s modiﬁed Eagles’ medium
(DMEM) supplemented with 10% fetal calf serum, 1% penicillin/
streptomycin, and 0.1 mM non-essential amino acids (Invitrogen,
Carlsbad, CA). HCV subgenomic replicon (genotype 1b) cells were
grown as we reported previously [5]. The infectious cell culture
grown virus (HCVcc) was generated as described previously [6].
The Jc1/GNDmutant containing an active sitemutation inNS5B that
destroys RNA-dependent RNApolymerase activitywas generated as
we previously reported [7]. The culture supernatant harvested from
cells transfected with Jc1/GND mutant RNA was used as a mock
infection. For virus infection experiments, cells were washed twice
with phosphate buffered saline (PBS) and infected for 4 h with
HCVcc at anm.o.i. of 1. HCVcc-infected cellswerewashed againwith
PBS and further grown in complete medium.
2.3. Generation of c-Fos stable cells
To make the cell lines stably expressing Flag-c-Fos, Huh7.5 cells
were transfected with the pFlag-CMV10-c-Fos expression plasmid
and cultured for 8 weeks in the presence of 300 lg/mL of G418.
Single positive clones were selected by immunoblot analysis using
anti-Flag monoclonal antibody. Huh7.5 cells transfected with
empty vector (pFlag-CMV10 only) were selected as described
above and used as a control.
2.4. siRNA transfection
C-Fos SMARTpool siRNA (ON-TARGETplus™) and 4 individual c-
Fos siRNA targeting different regions of the c-Fos mRNA were pur-
chased from Dharmacon (Lafayette, CO). siRNA targeting the 50NTR
of HCV (50-CCU CAA AGA AAA ACC AAA CUU-30) was used as a po-
sitive control [8]. Universal negative control siRNA (ON-TARGET-
plus™) was also purchased from Dharmacon. siRNA transfection
was performed using a Lipofectamine RNAiMax reagent (Invitro-
gen, Carlsbad, CA) as we described previously [7].
2.5. Quantiﬁcation of HCV RNA
RNA isolation from HCVcc-infected cells or cell culture medium
was performed using Trizol LS reagent (Invitrogen, Carlsbad, CA)
and reverse transcribed using ReverTra Ace-a- cDNA synthesis
kit (TOYOBO,Osaka, Japan) for 2 h at 42 C. cDNAwas ampliﬁedwith
HCV 50NTR-speciﬁc primers (forward, AGAGCCATAGTGGTCTGCGG-
AAC; reverse, CCTTTCGCAACCCAACGCTACTC), c-Fos-speciﬁc prim-
ers (forward, GACGGGCAAGGTGGAACAGTTATC; reverse, GTC
TGTCTCC CGCTTGGAGTGTATC), and actin-speciﬁc primers (for-
ward, CGCTCTCTGCTCCTCCTGTTC; reverse, CGCCCAATACGACCA
AATCCG). Quantitative real-time PCR (qPCR) experiments were
done using an iQ5 multicolor real-time PCR Detection system
(Bio-RadLaboratories, Hercules, CA) under the following conditions:
15 min at 95 C followed by 40 cycles of 95 C for 20 s, 55 C for 20 s,
72 C for 20 s. Seventy-one cycles of 10 s, with 0.5 C temperatureincrements from 60 to 95 C, were used for the melting curves to
monitor duplex hybridization. PCR products ampliﬁed with HCV
50NTR-speciﬁc primers were cloned into T-A vector (RBC) and used
as a standard for qPCR. The standards were run in parallel with the
samples and the HCV copy number was determined based on stan-
dard curve.
2.6. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay
Cell viability was determined using an EZ-CyTox cell viability as-
say kit (DAEILLAB, Korea) according to the manufacturer’s protocol.
2.7. Immunoblot analysis
Cells were lysed in cell lysis buffer containing 50 mMHEPES (pH
7.5), 150 mM sodium chloride (NaCl), 1 mMEDTA, 1% Nonidet P-40,
10%glycerol, andprotease inhibitor cocktail (Roche) for 5 minon ice.
The protein concentration was determined by the Bradford assay
(Bio-Rad). Equal amounts of proteins were subjected to either 8%
or 15% SDS–PAGE and electrotransferred to a nitrocellulose mem-
brane. The membrane was blocked in PBS containing 5% non-fat
dry milk for 1 h and then incubated 2 h at room temperature with
the indicated antibodies in Tris-buffered saline/Tween (20 mM
Tris–HCl (pH 7.5), 500 mM NaCl, and 0.05% Tween 20). Following
two washes in Tris-buffered saline/Tween 20, the membrane was
incubated with either horseradish peroxidase-conjugated goat
anti-rabbit antibodyor goat anti-mouseantibody (Jackson Immuno-
Research Laboratories, West Grove, PA) in Tris-buffered saline/
Tween for 1 h at room temperature. Proteins were detected using
an ECL kit (Amersham Biosciences).
2.8. Luciferase replication assay
6  106 Huh7.5 cells were electroporated with 10 lg of
in vitro transcribed JFH-Luc RNA. At 24 h after electroporation,
cells were transfected with 20 nM of siRNA for negative, positive,
and c-Fos, respectively. At 48 h after transfection, cells were har-
vested and then luciferase assays were performed as described
previously [9]. For dual luciferase reporter assay, cells were trans-
fected with 20 nM of indicated siRNAs for 24 h and then transfec-
ted with pRL-FL plasmid [10] together with beta-galactosidase
plasmid. Cell lysates harvested at 48 h after transfection were used
to determine both Renilla and ﬁreﬂy luciferase activities using
Dual-Luciferase Reporter Assay System (Promaga).
2.9. Immunoﬂuorescence assay
Huh7.5 cells cultured on glass slides were transfected with
either vector or Flag-c-Fos expression plasmid as indicated. At
24 h after transfection, cells were infected with either mock or
HCV Jc1. At 24 h postinfection, cells were washed in PBS and ﬁxed
with 4% paraformaldehyde and 0.1% Triton X-100 for 20 min at
37 C. Cells were incubated in PBS containing 5% bovine serum
albumin for 30 min at room temperature. Cells were then incu-
bated with the primary antibodies (rabbit anti-NS5A serum [11],
mouse anti-FLAG antibody (Sigma), respectively) for 2 h and fur-
ther incubated with the secondary antibodies (FITC-conjugated
goat anti-rabbit IgG, tetramethylrhodamine isothiocyanate
(TRITC)-conjugated donkey anti-mouse IgG (Jackson ImmunoRe-
search, Inc.) for 1 h at room temperature. After two washes with
0.1% Triton X-100 in PBS and three washes in PBS, cells were ana-
lyzed using the Zeiss LSM700 laser confocal microscopy system.
Dual staining indicates HCV protein expression in c-Fos expressing
cells. Either vector stable or c-Fos stable cells were also infected
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Fig. 1. Knockdown of c-Fos, but not other cell cycle-related genes, impairs HCV propagation. (A) Huh7.5 cells were transfected with 20 nM of siRNAs for 48 h and then
infected with HCV Jc1 for 4 h. At 2 days postinfection, culture supernatants were collected and extracellular HCV RNAs were quantiﬁed by qPCR. Pos, siRNA targeting the
50NTR of Jc1 as a positive control; Neg, the universal negative control siRNA. (B) Total cell lysates harvested from (A) were immunoblotted with the indicated antibodies. (C)
Huh7.5 cells were transfected with 20 nM negative (Neg), positive (Pos), or c-Fos siRNAs for 48 h, followed by infection with Jc1 for 4 h. At 2 days postinfection, c-Fos mRNAs
isolated from cells were analyzed by qPCR. (D) HCV replicon cells were transfected with the four individual siRNAs of c-Fos and allowed silencing for 48 h. Total RNAs were
extracted, and qPCR was performed to quantify the intracellular HCV RNA level (left panel) and the c-Fos mRNA level (right panel). Data from two independent experiments
were quantiﬁed. , p < 0.05; , p < 0.01. (E) Huh7.5 cells were transfected with the four individual siRNAs of c-Fos and allowed silencing for 48 h, and then infected with Jc1.
Both intracellular HCV RNA level (left panel) and the c-Fos mRNA level (right panel) were quantiﬁed as described above. (F) A schematic representation of pRL-FL dual-
luciferase reporter construct. The boxed area indicates siRNA target site for HCV RNA. (G) Huh7.5 cells were transfected with 20 nM of the indicated siRNAs. At 48 h after
transfection, cells were cotransfected with the pRL-HL plasmid and beta-galactosidase plasmid. At 24 h after plasmid transfection, cells were harvested and cell lysates were
used to analyze both Renilla and ﬁreﬂy luciferase activities. (H) Huh7.5 cells were transfected with the indicated siRNAs. At 96 h after transfection, cell viability was
determined by MTT assay.
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as described above.
2.10. DNA synthesis assay
Bromodeoxyuridine (5-bromo-20deoxyuridine, BrdU) incorpo-
ration into DNA was used for quantiﬁcation of DNA synthesis using
a BrdU incorporation assay kit according to the manufacturer’s
instructions (Cell proliferation ELISA, BrdU (colorimetric), Roche,
Penzberg, Germany). Brieﬂy, both vector stable and c-Fos stable
cells were seeded in 96-well plates and then labeled with BrdU
(10 lM) for 24 h at 37 C, washed, and ﬁxed in FixDenat solution
for 30 min and stained with anti-BrdU antibody for 90 min at room
temperature. After three washes, the substrate solution was added
until color development was sufﬁcient for photometric detection.
The absorbance of the samples was measured at 490 nmwith a ref-
erence wavelength of 690 nm using an ELISA reader.
2.11. Fluorescence-activated cell sorter (FACS) analysis
Huh7.5 cells were transfected with Neg, Pos, and c-Fos siRNAs,
respectively. At 24 h after transfection, cells were either mock-in-
fected or infected with Jc1-GFP. At 48 h postinfection, cells were
treated with Trypsin–EDTA and washed twice with buffer contain-
ing 1 MMgCl2 and 100 mM CaCl2 in PBS. HCV replicating cells were
counted and mean value of each experiment was analyzed using a
FACScan ﬂow cytometer (Becton Dickinson biosciences, San Diego,CA). For cell cycle analysis, Huh7.5 cells were transfected with
either negative or c-Fos siRNAs. At 24 h after transfection, cells
were either mock-infected or infected with Jc1. At 48 h postinfec-
tion, cells were harvested and ﬁxed in 70% ethanol for 30 min
and then centrifuged at 1500 rpm for 3 min. After washing in cold
PBS, cells were incubated in RNase A (20 lg/ml) at 37 C for
30 min, followed by staining of the DNA with propidium iodide
(50 lg/ml) for 30 min in the dark. Each sample was then analyzed
by FACScan ﬂow cytometer.
3. Results
3.1. c-Fos is a cellular factor involved in HCV propagation
HCV interferes with host cell cycle and exploits cellular proteins
to complete its life cycle. To identify the cellular proteins required
for HCV replication, we screened a siRNA library targeting 131
genes that control cell cycle in HCVcc-infected cells as we previ-
ously reported [7]. Huh7.5 cells were transfected with 20 nM of
siRNAs for 48 h and then infected with HCV Jc1 for 4 h. At 2 days
postinfection, culture supernatants were collected and extracellu-
lar HCV RNAs were quantiﬁed by qPCR. From 131 siRNA pools,
13 pools were identiﬁed as candidate hits [7]. These pools were re-
tested in a secondary screen. Cell viability was measured by MTT
assay. siRNA targeting 50NTR of HCV was used as a positive control.
Among candidate genes, we selected a gene encoding c-Fos for
further characterization because c-fos is involved in cell cycle pro-
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Fig. 1 (continued)
S.-M. Kang et al. / FEBS Letters 585 (2011) 3236–3244 3239gression and deregulation of c-Fos is a common phenomenon in
hepatocellular carcinoma [12]. c-Fos is one of immediate early
genes that is expressed at very low level in many tissues [4]. In
addition, c-Fos is rapidly and transiently activated by stimuli, and
its transcription and translation is regulated via a coupled mecha-
nism. c-Fos is also a highly unstable protein [13] with rapid nuclear
turnover. We ﬁrst investigated the effect of c-Fos on HCV propaga-tion by siRNA mediated knockdown experiments. Huh7.5 cells
were transfected with the indicated siRNAs for 48 h and then in-
fected with HCV Jc1. At 2 days postinfection, culture supernatants
were collected and extracellular HCV RNAs were quantiﬁed by
qPCR. CDC7 and CDC16 were also included as cell cycle related
control genes. As shown in Fig. 1A, extracellular HCV RNA level
was signiﬁcantly decreased in c-Fos knockdown cells. On the other
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Fig. 2. c-Fos is required for HCV replication. (A) c-Fos RNA level was increased in HCV-infected Huh7.5 cells. Huh7.5 cells were either mock-infected or Jc1-infected. At 48 h
postinfection, c-Fos RNA level was quantiﬁed by qPCR. Asterisks indicate signiﬁcant differences (, p < 0.05) from activity for the mock control. (B) PMA-induced c-Fos RNA
level was increased by HCV infection. Huh7.5 cells were either mock-infected or Jc1-infected. At 48 h postinfection, cells were either left untreated or treated with 40 ng/ml of
PMA. Following 8 h incubation, c-Fos RNA level was determined by qPCR. , p < 0.05, PMA treated mock versus Jc1 infection. (C) Knockdown of c-Fos reduced PMA-induced
HCV replication. Huh7.5 cells were transfected with the indicated siRNA duplexes. At 24 h after transfection, cells were infected with Jc1 for 4 h. At 48 h postinfection, cells
were either left untreated or treated with 40 ng/ml of PMA for 8 h. Total cell lysates were immunoblotted with the indicated antibodies. (–) indicates no siRNA transfection.
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extracellular HCV RNA level in HCVcc-infected cells, indicating that
c-Fos was speciﬁcally required for HCV replication. To further con-
ﬁrm this result, we investigated HCV protein expression levels in c-
Fos knockdown cells. Positive siRNA targeting 50NTR of HCV com-
pletely blocked NS5A and NS3 expressions (Fig. 1B, lane 2). Simi-
larly, silencing of c-Fos impaired HCV protein expressions
(Fig. 1B, lane 3). However, HCV protein expression levels were
not highly altered in cells treated with siRNA against CDC7 and
CDC16, respectively. We also determined transfection efﬁciency
of siRNAs by quantiﬁcation of c-Fos mRNA level. Fig. 1C showed
that c-Fos mRNA level was decreased 60% by c-Fos speciﬁc siR-
NAs as compared to universal negative siRNAs. To rule out the
off-target effects of c-Fos siRNA, we investigated the silencing ef-
fects using 4 siRNA duplexes designed to target different regions
of the c-Fos mRNA sequence. We demonstrated that all three siR-
NAs except #3 signiﬁcantly suppressed HCV RNA levels in both
HCV replicon (Fig. 1D) and Jc1-infected cells (Fig. 1E), indicating
that the effect of individual siRNA was c-Fos-speciﬁc. It was note-
worthy that knock-down efﬁciencies of c-Fos siRNAs between HCV
replicon cells and Jc1-infected cells were not exactly matched due
to different cell types (Huh7 cells harboring replicon versus Jc1
infected Huh7.5 cells) and siRNA treatment condition. However,
overall inhibitory patterns on HCV replication between two
systems were the same. To further examine whether HCV protein
expression was affected in cells treated with a c-Fos speciﬁc siRNA,
we performed reporter assay using dual-luciferase reporter
construct (pRL-FL) containing Renilla luciferase gene under CMV
prompter and ﬁreﬂy luciferase gene under HCV IRES (Fig. 1F). As
shown in Fig. 1G, both cap-dependent and HCV IRES-mediated
translations were not affected by knockdown of c-Fos, whereas
both reporter activities were signiﬁcantly decreased by HCV-spe-
ciﬁc siRNA treatment. Although HCV IRES-mediated translation is
regulated by cell cycle, these data indicated that HCV propagation
was regulated at the level of replication in cells treated with c-Fos
speciﬁc siRNA. To further examine whether siRNA transfection
caused cytotoxicity in Huh7.5 cells, we performed MTT assay. As
shown in Fig. 1H, silencing of cell cycle-related genes with 20 nM
of siRNA did not affect cell viability. Collectively, these data suggest
that c-Fos is required for HCV propagation.
3.2. HCV infection increases c-Fos expression
To investigate whether c-Fos level could be altered by HCV
infection, Huh7.5 cells were either mock-infected or Jc1-infected,
and c-Fos RNA levels were determined by qPCR. As shown inFig. 2A, c-Fos RNA level was signiﬁcantly increased in Jc1-infected
cells as compared to mock-infected cells. Nonetheless, endogenous
c-Fos protein was hardly detected by immunoblot analysis (data
not shown). Since phorbol 12-myristate 13-acetate (PMA) is a po-
tent and prolonged inducer of c-Fos and thus upregulates c-Fos
expression [14,15], we investigated whether PMA-induced c-Fos
was potentiated by HCV infection. For this purpose, Huh7.5 cells
were either mock-infected or Jc1-infected. At 48 h postinfection,
cells were either left untreated or treated with PMA and c-Fos
RNA level was determined by qPCR. Fig. 2B showed that c-Fos
RNA level in mock-infected cells was increased by PMA treatment.
As shown above, c-Fos RNA level was increased in HCV-infected
cells as compared to mock-infected cells (Fig. 2B, lane 3 versus lane
1). Moreover, PMA-induced c-Fos RNA level was additionally in-
creased by HCV infection (lane 4). Importantly, endogenous c-Fos
protein was well detected when HCV-infected cells were treated
with PMA (Fig. 2C, lane 2). Knockdown of c-Fos speciﬁcally im-
paired PMA-induced HCV replication (Fig. 2C, lane 4), conﬁrming
that c-Fos was required for HCV replication.
3.3. Overexpression of c-Fos enhances HCV propagation
Because silencing of c-Fos suppressed HCV propagation, we
hypothesized that overexpression of c-Fos might have positive
effect on HCV propagation. To determine this possibility, Huh7.5
cells were transfected with either empty vector or Flag-tagged
c-Fos expression plasmid. At 24 h after transfection, cells were
infected with Jc1. At 2 days postinfection, cell lysates were immu-
noblotted with the indicated antibodies. We showed that overex-
pression of c-Fos increased intracellular HCV protein level
(Fig. 3A). In parallel experiments, we further demonstrated that
overexpression of c-Fos increased both intracellular HCV RNA
(Fig. 3B) and extracellular HCV RNA levels (Fig. 3C). To further
investigate the effect of c-Fos on HCV replication, we established
c-Fos stable cell lines. For this purpose, Huh7.5 cells were transfec-
ted with Flag-c-Fos expression plasmid and c-Fos stable cells were
selected in the presence of G418. Both vector stable and c-Fos sta-
ble cells were infected with Jc1 and then total cell lysates were
immunoblotted with the indicated antibodies. As shown in
Fig. 3D, HCV protein level was also elevated in Jc1-infected c-Fos
stable cells as compared to the vector stable cells. We further
found that both HCV RNA and protein levels were increased in
other isolates of c-Fos stable cells (data not shown), conﬁrming
that this phenomenon was not due to clonal selection of c-Fos sta-
ble cells. We further conﬁrmed the functional activity of Flag-c-Fos
by reporter assay. Fig. 3E showed that Ap-1 reporter activity was
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were transfected with either vector or increasing amount of c-Fos expression plasmid. At 24 h after transfection, cells were infected with Jc1. At 24 h postinfection, cells were
immunostained with rabbit anti-NS5A serum (green) and mouse anti-Flag antibody (red). Dual staining indicates HCV protein expression in c-Fos expressing cells. Nuclei
were visualized by staining cells with DAPI. (Right panel) Either vector stable or c-Fos stable cells were infected with Jc1 and immunostained as described above.
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tor stable cells. This result indicates that ectopic expression of c-
Fos has the functional activity and thus the increased expression
of c-Fos in the nucleus resulted in upregulation of AP-1 reporter
activity. To examine whether modulation of c-Fos expression af-
fected cellular proliferation, BrdU-incorporation assay was per-
formed in c-Fos stable cells. As shown in Fig. 3F, BrdU-
incorporation rates in c-Fos stable cells were comparable to vector
stable cells. This indicated that c-Fos overexpression did not affect
cellular proliferation. We then analyzed the effect of silencing of c-
Fos on cell cycle. Silencing of c-Fos did not alter the cell cycle as in
cells treated with universal negative siRNAs (data not shown).
These data indicated that cellular proliferation was not affected
either by overexpression or silencing of c-Fos. To further verify
the positive effect of c-Fos on HCV, HCV propagation was measured
by detecting the NS5A protein expression using immunoﬂuores-
cence assay. Fig. 3G showed that HCV propagation was increased
in cells transiently expressing c-Fos in a dose-dependent manner
(left panel). We further conﬁrmed that HCV propagation was in-
creased in c-Fos stable cells as compared to the vector stable cells
(Fig. 3G, right panel). It was noteworthy that c-Fos protein was not
always detected in HCV positive cells although c-Fos level was in-
creased by HCV infection. In addition, both NS5A and c-Fos do not
colocalize at higher magniﬁcation because c-Fos is primarily local-
ized in nucleus and NS5A is preferentially localized in the cyto-plasm (data not shown). Together, these results indicate that c-
Fos is a positive regulator for HCV propagation.
3.4. HCV replication is c-Fos-dependent as determined by reporter and
FACS analyses
To further demonstrate the role of c-Fos in HCV replication,
luciferase-tagged full-length JFH1 HCV RNA construct (HCV-Luc,
Fig. 4A) [16,17] was employed for reporter assay. In this construct,
HCV proteins are expressed via an internal ribosomal entry site
(IRES) of EMCV [18]. Huh7.5 cells were electroporated with JFH1-
Luc RNA, transfected with c-Fos expression plasmid, and then lucif-
erase activity was determined. Fig. 4B showed that HCV reporter
activity was increased by c-Fos in a dose-dependent manner. We
further demonstrated that HCV replication was increased by two-
fold at 24 h and then rapidly increased at 48 h after c-Fos transfec-
tion (Fig. 4C). To verify the positive role of c-Fos in HCV replication,
Huh7.5 cells electroporated with HCV-Luc were transfected with
20 nM of indicated siRNAs. Indeed, silencing of c-Fos impaired
HCV reporter activity (Fig. 4D, upper panel). It was noteworthy that
the suppressive activity of c-Fos siRNA on HCV replication was
comparable to positive siRNA (Fig. 4D, lane 4 versus lane 5 in upper
panel). This was further conﬁrmed in protein level by immunoblot
analysis (Fig. 4D, lower panel). To further investigate the positive
effect of c-Fos on HCV replication, we employed FACS analysis
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3242 S.-M. Kang et al. / FEBS Letters 585 (2011) 3236–3244using Jc1-GFP viruses. Huh7.5 cells were either left untransfected
or transfected with negative, positive, and c-Fos siRNAs, respec-
tively. At 24 h after transfection, cells were either mock-infected
or infected with Jc1-GFP for 4 h. HCV replication was determined
by measuring green ﬂuorescence protein (GFP) signals. Mean M2
was considered to be the number of HCV replicating cells. Techni-
cally, M2 signals in mock-infected cells were designated as back-
ground noise. As shown in Fig. 4E, M2 was signiﬁcantly increased
in Jc1-GFP-infected cells as compared to mock-infected cells (from
15.99 to 570.95). M2 was minimally affected by negative siRNA,
whereas M2 level was signiﬁcantly decreased by c-Fos siRNA treat-
ment. Knockdown of c-Fos impaired HCV replication as potent as
positive siRNA treatment. These data suggest that c-Fos is an
important cellular factor involved in HCV replication.
4. Discussion
HCV RNA replication occurs on the membranous web in the
cytoplasm and requires cellular proteins for its own propagation
[19]. To date, many cellular factors have been identiﬁed to be in-
volved in HCV replication and propagation [20]. Human vesicle-
associated protein 33 (hVAP-33) interacts with both NS5A and
NS5B and plays an essential role in assembly of the HCV replication
complex [21,22]. FK506-binding protein 8 (FKBP8) interacts with
NS5A with heat shock protein 90 (HSP90) to generate the replica-
tion complex [23]. Human butyrate-induced transcript 1 (hB-ind1)
participates in the formation of the replication complex by interac-tion with NS5A [24]. Raf-1 kinase regulates HCV replication
through the interaction with C-terminal region of NS5A [25]. We
and other groups recently reported that PI4KIIIa is an essential
host factor that supports HCV propagation [26–29]. To identify
host factors necessary for HCV propagation, we screened siRNA li-
brary targeting cell cycle in HCVcc-infected cells. Out of 11 candi-
date hits that decreased in extracellular HCV RNA [8], we selected
and characterized a gene encoding c-Fos. c-Fos is a member of the
immediate early gene family, and comprises AP-1 transcription
factor by forming a heterodimer with c-Jun [30]. c-Fos regulates
cell proliferation, differentiation, apoptosis, and transformation
[30]. In addition, deregulation of c-Fos results in pathogenic events
including, skeletal, neurological, and immunological defects, as
well as oncogenic transformation and tumor progression [31,32].
AP-1 complex is primarily considered to be oncogenic, whereas
some AP-1 proteins have been shown to have tumor-suppressor
activity [30,33,34].
In the present study, we showed that knockdown of c-Fos sig-
niﬁcantly reduced extracellular HCV RNA as well as intracellular
HCV RNA and protein expressions, suggesting that c-Fos was re-
quired for HCV replication. We found that HCV infection increased
c-Fos expression level. Furthermore, overexpression of c-Fos ele-
vated HCV propagation. This was further conﬁrmed in c-Fos stable
cells where HCV propagation was highly increased as compared to
the vector stable cells. To examine whether the effect of c-Fos on
HCV replication was genotype-speciﬁc, both genotype 1b (HCV
replicon) and genotype 2a (HCV Jc1) were compared for HCV
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Fig. 4. c-Fos is an essential cellular factor involved in HCV propagation. (A) Genetic organization of JFH1-derived luciferase reporter construct (JFH1-Luc). (B) Huh7.5 cells
were electroporated with in vitro transcribed JFH1-Luc RNA. At 24 h after electroporation, cells were transfected with increasing amounts of c-Fos expression plasmid
together with 0.1 lg of b-galactosidase. At 24 h after transfection, cells were harvested and then luciferase reporter activity was determined. Data represent the mean of three
independent experiments. (C) Huh7.5 cells were electroporated with JFH1-Luc RNA. At 24 h after electroporation, cells were transfected with 0.5 lg of c-Fos expression
plasmid together with 0.1 lg of b-galactosidase. Cells were harvested at the indicated time and luciferase activities were determined. (D) Knockdown of c-Fos impaired HCV
replication in JFH1-Luc reporter system. Huh7.5 cell were electroporated with in vitro transcribed JFH1-Luc RNA. At 24 h after electroporation, cells were transfected with
20 nM of indicated siRNAs. At 48 h after transfection, cells were harvested and then luciferase reporter activity was determined. Data represent the mean of three
independent experiments (upper panel). Equal amounts of cell lysates were immunoblotted with rabbit anti-NS5A serum and anti-GAPDHmonoclonal antibody, respectively
(lower panel). (E) Knockdown of c-Fos impaired HCV replication as determined by FACS analysis. Huh7.5 cells were transfected with Neg, Pos, and c-Fos siRNAs, respectively.
At 24 h after transfection, cells were either mock-infected or infected with Jc1-GFP for 48 h. HCV replicating cells were counted and mean value of each experiment was
determined by FACS analysis. (–) indicates no siRNA transfection. Green ﬂuorescence (M2) represents HCV NS5A staining.
S.-M. Kang et al. / FEBS Letters 585 (2011) 3236–3244 3243RNA replication in the presence of ectopic c-Fos protein expression.
We found that c-Fos increased HCV replication in both replicon
(data not shown) and Jc1-infected cells, indicating that modulation
of HCV replication by c-Fos was irrespective of HCV genotypes.
PMA upregulates the expression of c-Fos and c-Jun, and stimu-
lates the c-Fos serum response element (SRE) [14,15]. In the presentstudy, we investigated whether PMA-induced c-Fos level could be
modulated by HCV infection. We showed that PMA-induced c-Fos
RNA level was synergistically elevated by HCV infection. Further-
more, knockdownof c-Fos impairedPMA-inducedHCVpropagation.
Taken together, our data provide an essential role of c-Fos in HCV
propagation. c-Fos expression level was upregulated by HCV infec-
3244 S.-M. Kang et al. / FEBS Letters 585 (2011) 3236–3244tion and elevated c-Fos in turn promotedHCV propagation. It is pos-
sible that the elevated c-Fos level inHCV-replicating cellsmay affect
the genetic integrity of the host cell and thereby contribute to the
development of HCC. These data imply that c-Fos may be involved
in HCV-associated pathogenesis.
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